Bladder Cancer
FEATURES
avatar
741 clinical trials
avatar
241 cell line models
avatar
9 approved drugs
IMAGE
Bladder Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

9 drugs have received FDA approval for Bladder Cancer:

  • Atezolizumab
  • Avelumab
  • Cisplatin
  • Doxorubicin Hydrochloride
  • Durvalumab
More

164 drugs have a clinical trial registered for Bladder Cancer.

598 compounds have been tested in Bladder Cancer (410 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 741 clinical trials for Bladder Cancer, 440 of which have one or more drug interventions, 301 with no drug intervention.
Cell line models

There are 241 Cell Line Models for Bladder Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Bladder Cancer:
  • Ureteral Neoplasms
  • Urethral Neoplasms
  • Urologic Neoplasms
  • Urinary Bladder Neoplasms
The following terms have been mapped from cancer.gov to Bladder Cancer:
  • Urothelial carcinoma (a type of bladder cancer) that is locally advanced or has metastasized. It is used in:Patients whose cancer has the PD-L1 protein and cannot be treated with cisplatin
  • Bladder cancer that cannot be treated with surgery or radiation therapy
  • Urothelial carcinoma (a type of bladder cancer) that is locally advanced or has metastasized. It is used in patients whose disease got worse during or after treatment with platinum chemotherapy
  • Hemorrhagic cystitis (bleeding in the bladder) caused by chemotherapy with ifosfamide
  • Urothelial carcinoma (a type of bladder cancer) that is locally advanced or has metastasized. It is used in patients whose disease got worse during or after treatment with platinum chemotherapy
More